These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1779727)

  • 1. Enteric MRI contrast agents: comparative study of five potential agents in humans.
    Tart RP; Li KC; Storm BL; Rolfes RJ; Ang PG
    Magn Reson Imaging; 1991; 9(4):559-68. PubMed ID: 1779727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paramagnetic oil emulsions as oral magnetic resonance imaging contrast agents.
    Li KC; Ang PG; Tart RP; Storm BL; Rolfes R; Ho-Tai PC
    Magn Reson Imaging; 1990; 8(5):589-98. PubMed ID: 2082129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of oral contrast agents for abdominal magnetic resonance imaging.
    Kraus BB; Rappaport DC; Ros PR; Torres GM
    Magn Reson Imaging; 1994; 12(6):847-58. PubMed ID: 7968284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation of radiographically detectable gastrointestinal contrast agents for magnetic resonance imaging: effects of a barium sulfate additive on MR contrast agent effectiveness.
    Rubin DL; Muller HH; Young SW
    Magn Reson Med; 1992 Jan; 23(1):154-65. PubMed ID: 1734177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Kaopectate with barium for negative and positive enteric contrast at MR imaging.
    Mitchell DG; Vinitski S; Mohamed FB; Mammone JF; Haidet K; Rifkin MD
    Radiology; 1991 Nov; 181(2):475-80. PubMed ID: 1924791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Two Neutral Oral Contrast Agents in Pediatric Patients: A Prospective Randomized Study.
    Dillman JR; Towbin AJ; Imbus R; Young J; Gates E; Trout AT
    Radiology; 2018 Jul; 288(1):245-251. PubMed ID: 29737955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Barium sulfate suspension as a negative oral MRI contrast agent: in vitro and human optimization studies.
    Li KC; Tart RP; Fitzsimmons JR; Storm BL; Mao J; Rolfes RJ
    Magn Reson Imaging; 1991; 9(2):141-50. PubMed ID: 2034046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral contrast agents for small bowel distension in MRI: influence of the osmolarity for small bowel distention.
    Ajaj W; Goyen M; Schneemann H; Kuehle C; Nuefer M; Ruehm SG; Goehde SC; Lauenstein TC
    Eur Radiol; 2005 Jul; 15(7):1400-6. PubMed ID: 15754160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Head-to-head comparison of oral contrast agents for cross-sectional enterography: small bowel distention, timing, and side effects.
    Young BM; Fletcher JG; Booya F; Paulsen S; Fidler J; Johnson CD; Huprich J; Barlow J; Trout A
    J Comput Assist Tomogr; 2008; 32(1):32-8. PubMed ID: 18303285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MR imaging of the gastrointestinal tract with i.v., gadolinium and diluted barium oral contrast media compared with unenhanced MR imaging and CT.
    Low RN; Francis IR
    AJR Am J Roentgenol; 1997 Oct; 169(4):1051-9. PubMed ID: 9308464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of nutritional support formula as a gastrointestinal contrast agent for MRI.
    Mirowitz SA; Susman N
    J Comput Assist Tomogr; 1992; 16(6):908-15. PubMed ID: 1430440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Techniques for high-resolution echo-planar MR imaging of the pancreas.
    Reimer P; Saini S; Hahn PF; Mueller PR; Brady TJ; Cohen MS
    Radiology; 1992 Jan; 182(1):175-9. PubMed ID: 1727278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [MR imaging oral contrast agent mixed with milk for the small intestine].
    Hirohashi S; Hirohashi R; Uchida H; Kitano S; Tanaka M; Matsuo N; Ohishi H
    Nihon Igaku Hoshasen Gakkai Zasshi; 1994 Jul; 54(8):784-8. PubMed ID: 8072869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positive bowel contrast agent for MR imaging of the abdomen: phase II and III clinical trials.
    Patten RM; Lo SK; Phillips JJ; Bowman SC; Glazer GM; Wall SD; Bova JG; Harris RD; Wheat RL; Johnson CD
    Radiology; 1993 Oct; 189(1):277-83. PubMed ID: 8372205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Patient Tolerance and Small-Bowel Distention With a New Small-Bowel Distending Agent for Enterography.
    Kolbe AB; Fletcher JG; Froemming AT; Sheedy SP; Koo CW; Pundi K; Bruining DH; Tung J; Harmsen WS; Barlow JM; Fidler JL
    AJR Am J Roentgenol; 2016 May; 206(5):994-1002. PubMed ID: 26998661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low density barium and bentonite mixture versus high density barium: a comparative study to optimize negative gastrointestinal contrast agents for MRI.
    Paley MR; Nicolas AI; Mergo PJ; Torres GM; Burton SS; Ros PR
    Magn Reson Imaging; 1997; 15(9):1033-6. PubMed ID: 9364949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimization of a contrast medium suitable for conventional enteroclysis, MR enteroclysis, and virtual MR enteroscopy.
    Papanikolaou N; Prassopoulos P; Grammatikakis J; Maris T; Kouroumalis E; Gourtsoyiannis N
    Abdom Imaging; 2002; 27(5):517-22. PubMed ID: 12172989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Large scale clinical evaluation of bowel contrast agent containing ferric ammonium citrate in MRI.
    Hirohashi S; Uchida H; Yoshikawa K; Fujita N; Ohtomo K; Yuasa Y; Kawamura Y; Matsui O
    Magn Reson Imaging; 1994; 12(6):837-46. PubMed ID: 7968283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fat-density oral contrast agent for abdominal CT.
    Raptopoulos V; Davis MA; Davidoff A; Karellas A; Hays D; D'Orsi CJ; Smith EH
    Radiology; 1987 Sep; 164(3):653-6. PubMed ID: 3615862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. OMR, a positive bowel contrast agent for abdominal and pelvic MR imaging: safety and imaging characteristics.
    Patten RM; Moss AA; Fenton TA; Elliott S
    J Magn Reson Imaging; 1992; 2(1):25-34. PubMed ID: 1623278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.